LABT Lakewood-Amedex Biotherapeutics Inc.

NASDAQ
$0.93

Lakewood-Amedex Biotherapeutics Inc. (LABT) is expected to report earnings on November 12, 2026, during market hours. The consensus earnings estimate is $0.81 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -60.3% since its last earnings release on August 13, 2026.

Lakewood-Amedex Biotherapeutics Missed Consensus Estimates
Thursday, August 13, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · Market Hours
Earnings Whisper
-
vs $0.81
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.69

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.